Government agencies and non-profits at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

7 government agencies and non-profits are at PepTalk 2027 — 16 presentations on the program. Most represented: Frederick National Laboratory for Cancer Research (3 on the program), U.S. Food and Drug Administration (1 on the program), Lawrence Livermore National Laboratory (1 on the program). 6 of them have their own page in this guide. As of Oct 17, 2026.

All 166 organizations at PepTalk 2027 →

Showing 1–7 of 7 organizations

Organization	PepTalk 2027 Attendance
Frederick National Laboratory for Cancer Research Frederick, MD
frederick.cancer.gov Gov/NGO Federally funded biomedical research laboratory sponsored by the National Cancer Institute and operated by Leidos Biomedical Research.	Chair Mon Jan 18 8:50am–9:00am Chairperson's Opening Remarks SYMPOSIUM: (Re) Discovering Protein Expression Platforms Talk Mon Jan 18 9:00am–9:30am From Construct to Culture: Plotting a Path in Protein Production SYMPOSIUM: (Re) Discovering Protein Expression Platforms Talk Mon Jan 18 10:00am–10:30am Comparison of Insect Cell Expression Technologies SYMPOSIUM: (Re) Discovering Protein Expression Platforms Talk Tue Jan 19 11:20am–11:50am Yield and Concentration Improvements in RAF1 Ras-Binding Domain and Cysteine-Rich Domain Recombinant Protein Production - Part 1
U.S. Food and Drug Administration Silver Spring, MD
fda.gov Gov/NGO US agency that regulates drugs, biologics and medical devices; its Center for Drug Evaluation and Research reviews new drug applications.	Talk Wed Jan 20 3:30pm–4:00pm Therapeutic Peptide Products: Toward Greater Regulatory Clarity in the Assessment and Mitigation of Immunogenicity Risks Peptide Therapeutics: Emerging Modalities & Development Panel Wed Jan 20 5:40pm–6:10pm Stick to the Science—How Evidence Generation Can Build upon Technology Enthusiasm to Advance Both Regulatory Certainty and Market Momentum Peptide Therapeutics: Emerging Modalities & Development · with Novartis, U.S. Pharmacopeia, ELIQUENT Life Sciences Chair Thu Jan 21 1:35pm–1:40pm Chairperson's Remarks Peptide Therapeutics: Emerging Modalities & Development
Lawrence Livermore National Laboratory Livermore, CA
llnl.gov Gov/NGO US Department of Energy national security laboratory whose bioscience work includes medical countermeasures and cell-free protein systems.	Chair Mon Jan 18 1:30pm–1:35pm Chairperson's Remarks SYMPOSIUM: Predictive Protein Production Talk Mon Jan 18 3:30pm–4:00pm Cell-Free Synthetic Reconstruction of Human Voltage-Gated Ion Channel Systems for Rapid Functional Characterization, Regulatory Network Analysis, and Countermeasure Development SYMPOSIUM: Predictive Protein Production
LifeArc London, UK
lifearc.org Gov/NGO UK medical research charity that funds translational research and runs its own drug discovery, including antibodies and other biologics.	Talk Tue Jan 19 8:40am–9:10am A Funnelled Protein Production Strategy to Enable Early Tractability Assessment Recombinant Protein Production - Part 1 Chair Wed Jan 20 8:30am–8:35am Chairperson's Remarks Recombinant Protein Production - Part 1
Los Alamos National Laboratory Los Alamos, NM
lanl.gov Gov/NGO US Department of Energy national security laboratory with bioscience research, including protein expression and machine-learning work.	Panel Tue Jan 19 1:30pm–2:00pm Building Better Data for Predictive Protein Expression Recombinant Protein Production - Part 1 · with University College London, University of Surrey, Cell-Free Group +1 more Talk Tue Jan 19 2:30pm–3:00pm SignalGen: A Protein Language Model Based AI Agent for Optimal Signal Peptide Prediction Recombinant Protein Production - Part 1
U.S. Pharmacopeia Rockville, MD
usp.org Gov/NGO Non-profit that sets public quality standards and supplies reference materials for medicines, including peptides and biologics.	Talk Wed Jan 20 3:00pm–3:30pm Building Robust Control Strategies for Peptide APIs: From Synthesis to Regulatory Approval Peptide Therapeutics: Emerging Modalities & Development Panel Wed Jan 20 5:40pm–6:10pm Stick to the Science—How Evidence Generation Can Build upon Technology Enthusiasm to Advance Both Regulatory Certainty and Market Momentum Peptide Therapeutics: Emerging Modalities & Development · with U.S. Food and Drug Administration, Novartis, ELIQUENT Life Sciences
National Cancer Institute Bethesda, MD
cancer.gov Gov/NGO US federal agency within the National Institutes of Health for cancer research and training.	Talk Wed Jan 20 3:30pm–4:00pm Directing T Cells to a Non-Shed Mesothelin Epitope to Overcome a Key Barrier in Antibody-Based Cancer Immunotherapy Emerging T Cell Engagers